Liaoning Chengda (China) Today
| 688739 Stock | 28.82 0.16 0.56% |
PerformanceInsignificant
| Odds Of DistressVery Low
|
Liaoning Chengda is trading at 28.82 as of the 27th of February 2025, a 0.56% up since the beginning of the trading day. The stock's open price was 28.66. Liaoning Chengda has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 29th of November 2024 and ending today, the 27th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Liaoning Chengda is entity of China. It is traded as Stock on SHG exchange. The company has 416.45 M outstanding shares. More on Liaoning Chengda Biotechnology
Moving together with Liaoning Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Liaoning Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Liaoning Chengda's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Liaoning Chengda or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Liaoning Chengda Biotechnology (688739) is traded on Shanghai Stock Exchange in China and employs 1,732 people. Liaoning Chengda is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Liaoning Chengda's market, we take the total number of its shares issued and multiply it by Liaoning Chengda's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Liaoning Chengda Bio operates under Biotechnology sector and is part of Health Care industry. The entity has 416.45 M outstanding shares.
Liaoning Chengda generates positive cash flow from operations, but has no cash available
Check Liaoning Chengda Probability Of Bankruptcy
Ownership AllocationLiaoning Chengda Bio maintains a total of 416.45 Million outstanding shares. Liaoning Chengda Biotechnology holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Liaoning Ownership Details
Liaoning Chengda Bio Risk Profiles
Although Liaoning Chengda's alpha and beta are two of the key measurements used to evaluate Liaoning Chengda's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.23 | |||
| Semi Deviation | 1.53 | |||
| Standard Deviation | 1.83 | |||
| Variance | 3.33 |
Liaoning Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Liaoning Chengda without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Liaoning Chengda Corporate Management
Elected by the shareholders, the Liaoning Chengda's board of directors comprises two types of representatives: Liaoning Chengda inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Liaoning. The board's role is to monitor Liaoning Chengda's management team and ensure that shareholders' interests are well served. Liaoning Chengda's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Liaoning Chengda's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Weiqiang Sun | Deputy Scientist | Profile | |
| Deming Yuan | Deputy Manager | Profile | |
| Libao Zhou | Deputy Officer | Profile | |
| Yu Mao | General Manager | Profile | |
| Zhumu Bai | Deputy Mang | Profile |
Other Information on Investing in Liaoning Stock
Liaoning Chengda financial ratios help investors to determine whether Liaoning Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Liaoning with respect to the benefits of owning Liaoning Chengda security.